Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - INTERLEUKIN GENETICS INCFinancial_Report.xls
EX-31.2 - CERTIFICATION - INTERLEUKIN GENETICS INCv385476_ex31-2.htm
EX-31.1 - CERTIFICATION - INTERLEUKIN GENETICS INCv385476_ex31-1.htm
10-Q - FORM 10-Q - INTERLEUKIN GENETICS INCv385476_10q.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
UNITED STATES CODE)

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18 United States Code), each of the undersigned officers of Interleukin Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

 

The Quarterly Report of Form 10-Q for the quarter ended June 30, 2014 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 13, 2014 /s/ Kenneth S. Kornman
 

Kenneth S. Kornman

Chief Executive Officer

   
Date: August 13, 2014 /s/ Eliot M. Lurier
 

Eliot M. Lurier

Chief Financial Officer